Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 91
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03214627 | Artificial Intelligence for Optimal Anemia Management in End-stage Renal Disease: The Anemia Control Model (ACM) Trial | ||
| NCT06434025 | IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency | ||
| NCT03644264 | PA21 Safety and Efficacy in Adult Chinese Subjects | ||
| NCT03759964 | Effects of Ferinject® on Anemia and Transfusion Rates After Cardiac Surgery | ||
| NCT01100879 | Ferric Carboxymaltose for Treatment of Anaemia of Cancer in Subjects With Multiple Myeloma Receiving Chemotherapy | ||
| NCT05897684 | Avacostar - (PASS) | ||
| NCT02688764 | A Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia | ||
| NCT01453608 | A Study to Compare the Use of Ferric Carboxymaltose With Placebo in Patients With Chronic Heart Failure and Iron Deficiency | ||
| NCT01913808 | Comparing Intravenous and Oral Iron in Postoperative Anemia | ||
| NCT01464190 | A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients | ||
| NCT05415969 | CKD-aP Among Adults on Dialysis in Switzerland | ||
| NCT01975272 | The Use of Iron Therapy for Patients With Anemia After Caesarean Section | ||
| NCT03957187 | Prevalence and Clinical Associates of Iron Deficiency in Patients With Atrial Fibrillation | ||
| NCT01057004 | EVIdence Based TreAtment - Heart Failure (EVITA-HF) | ||
| NCT03010072 | The Effect of Phosphate Lowering Using Sucroferric Oxyhydroxide (PA21) on Calcification Propensity of Serum | ||
| NCT01345968 | Intravenous Ferric Carboxymaltose (Ferinject) in Patients Undergoing Orthopaedic Surgery | ||
| NCT02125344 | A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto) | ||
| NCT02694744 | Patiromer With or Without Food for the Treatment of Hyperkalemia | ||
| NCT00706667 | Intravenous Ferric Carboxymaltose (Ferinject®) With or Without Erythropoietin in Patients Undergoing Orthopaedic Surgery | ||
| NCT05751772 | Improving Knowledge in Heart Failure Inpatient With Therapeutic Education | ||
| NCT00810004 | Maintenance Treatment of Iron Deficiency in IBD Patients | ||
| NCT05136664 | Trial Evaluating the Efficacy and Safety of Patiromer in Chinese Subjects | ||
| NCT00882414 | Ferinject® in Patient With Thrombocytosis Secondary to Inflammatory Bowel Disease (IBD) | ||
| NCT05034250 | Iron Status in Female Infertility and Recurrent Miscarriage | ||
| NCT04364269 | Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Preliminary Efficacy of VIT-2763 in β-thalassaemia | ||
| NCT05786469 | Patiromer Trial in CKD Stage IIIB to V | ||
| NCT01513369 | Ferric Carboxymaltose in Type 2 Diabetes Mellitus (T2DM) Patients With Iron Deficiency | ||
| NCT02147795 | The German Patient Blood Management Network | ||
| NCT05389826 | mHealth for Phosphorus Management in CKD. | ||
| NCT04864795 | Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalaemia or at High Risk of Hyperkalaemia | ||
| NCT00810030 | FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR | ||
| NCT04806048 | Feasibility of Implementation of Recommended Standards in Patients With Heart Failure | ||
| NCT04938635 | Efficacy and Safety Study of Multiple Doses of VIT-2763 in Adults With Transfusion-dependent Beta-thalassemia | ||
| NCT03071263 | Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease | ||
| NCT05885763 | Pharmacokinetics of Intravenous Difelikefalin in Chinese Adult Subjects on Haemodialysis | ||
| NCT00868439 | Evaluation of Patiromer in Heart Failure Patients | ||
| NCT05766839 | Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age | ||
| NCT01810939 | A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia (OPAL) | ||
| NCT04903717 | Pragmatic Trial Of Alerts for Use of Mineralocorticoid Receptor Antagonists | ||
| NCT00821717 | EFfect of Ferric Carboxymaltose on exercIse CApacity and Cardiac Function in Patients With Iron deficiencY and Chronic Heart Failure | ||
| NCT05460234 | RAYALDEE Non Interventional Study (NIS) on Effectiveness in ND-CKD SHPT Patients | ||
| NCT02033317 | An Open-Label, Multiple Dose Study to Evaluate the Pharmacology, Safety, and Tolerability of Patiromer in Participants on Hemodialysis | ||
| NCT03769441 | Effect of Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation | ||
| NCT03591406 | To Assess the Impact of Ferric Carboxymaltose Compared With Iron Sucrose in Chinese Subjects on Correcting Iron Deficiency Anaemia | ||
| NCT02232906 | Switch From Oral Iron to Intravenous Ferric Carboxymaltose in Non-dialysis Chronic Kidney Disease (CKD) | ||
| NCT05077436 | Bioavailability Study Comparing 2 Vamifeport Oral Formulations in Fasted Versus Fed State in Healthy Subjects | ||
| NCT00994318 | Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) | ||
| NCT01452906 | A Drug-Drug Interaction Study of Omeprazole and PA21 | ||
| NCT01131624 | Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women | ||
| NCT04817670 | Study to Assess Efficacy and Safety of VIT-2763 (Vamifeport) in Subjects With Sickle Cell Disease |
